Aethlon Medical Inc (AEMD): Kapitalisasi marang pendapatan
The growth of Aethlon Medical (AEMD) is fundamentally driven by macro resilience and dependence on the FDA rather than the broader economy. This P/S ratio chart from GURU.Markets confirms this, with the current parameter standing at 9.60. Management is leading development by implementing the Hemopurifier to combat infections. A stable moat is provided by a unique exosome filter and stringent regulatory barriers within the medtech sector.
Rincian analitis perusahaan Aethlon (AEMD)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Aethlon Medical|AEMD - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Aethlon Medical Corp|AEMD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Aethlon|AEMD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Aethlon Medical|Rasio jangkoan perantara aethlonmedical.com
- data bathi lan kelipatan valuasi:
AEMD - Bathi resik|Bathi resik sing dikarepake Aethlon Medical|AEMD - Rasio rega marang bathi|Pangali forward rega marang bathi Aethlon Medical Inc|AEMD - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Aethlon|AEMD - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Aethlon Medical|AEMD - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan aethlonmedical.com|AEMD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Aethlon Medical
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:AEMD aethlonmedical.com
High patent barriers and FDA compliance for Aethlon Medical (AEMD) hemosorption cartridges create unique market value, which the current P/S ratio aligns with actual sales volume. This multiple, by dividing market capitalization by annual revenue, allows an investor to determine a fair valuation range for the asset and identify the risk of a fundamental loss of position should the indicator remain at historical lows for a prolonged period.
Pesaing Aethlon Medical
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS - Kapitalisasi marang pendapatan|Multiplikator P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corporation)|Rasio rega marang pendapatan Sensus Healthcare Corp|Kapitalisasi marang pendapatan Zynex Corp (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan Inspira Technologies IINN|ICU: Rasio kapitalisasi marang pendapatan|IRIX: Kapitalisasi marang pendapatan|Intelligent Bio Solutions - Kapitalisasi marang volume dodolan|XAIR: Multiplikator P/S|profusa.com (PFSA) - Multiplikator P/S|SSKN (STRATA Skin Sciences Inc.) - Multiplikator P/S|Rega marang dodolan glucotrack.com GCTK|Kapitalisasi marang pendapatan NAOV (NanoVibronix)|Kapitalisasi marang volume dodolan VERO|Multiplikator P/S NUWE (Nuwellis, Inc.)|Rasio kapitalisasi pasar marang pendapatan ASXC|AVGR - Rasio rega marang pendapatan|BSGM: Rasio rega marang pendapatan|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|Rega marang dodolan Know Labs Corporation (KNW)|Rasio rega marang pendapatan Inari Medical, Inc.|Rasio kapitalisasi marang pendapatan NVRO (nevro.com)|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
